Skip to main content

Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.

Publication ,  Journal Article
Gierisch, JM; Coeytaux, RR; Urrutia, RP; Havrilesky, LJ; Moorman, PG; Lowery, WJ; Dinan, M; McBroom, AJ; Hasselblad, V; Sanders, GD; Myers, ER
Published in: Cancer Epidemiol Biomarkers Prev
November 2013

Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted a systematic review to estimate associations between oral contraceptive use and breast, cervical, colorectal, and endometrial cancer incidence. We searched PubMed, Embase, and Cochrane Database of Systematic Reviews. Study inclusion criteria were women taking oral contraceptives for contraception or ovarian cancer prevention; includes comparison group with no oral contraceptive use; study reports quantitative associations between oral contraceptive exposure and relevant cancers; controlled study or pooled patient-level meta-analyses; sample size for nonrandomized studies ≥100; peer-reviewed, English-language; published from January 1, 2000 forward. Random-effects meta-analyses were conducted by estimating pooled ORs with 95% confidence intervals (CIs). We included 44 breast, 12 cervical, 11 colorectal, and 9 endometrial cancers studies. Breast cancer incidence was slightly but significantly increased in users (OR, 1.08; CI, 1.00-1.17); results show a higher risk associated with more recent use of oral contraceptives. Risk of cervical cancer was increased with duration of oral contraceptive use in women with human papillomavirus infection; heterogeneity prevented meta-analysis. Colorectal cancer (OR, 0.86; CI, 0.79-0.95) and endometrial cancer incidences (OR, 0.57; CI, 0.43-0.77) were significantly reduced by oral contraceptive use. Compared with never use, ever use of oral contraceptives is significantly associated with decreases in colorectal and endometrial cancers and increases in breast cancers. Although elevated breast cancer risk was small, relatively high incidence of breast cancers means that oral contraceptives may contribute to a substantial number of cases.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

November 2013

Volume

22

Issue

11

Start / End Page

1931 / 1943

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • Ovarian Neoplasms
  • Humans
  • Female
  • Epidemiology
  • Endometrial Neoplasms
  • Contraceptives, Oral
  • Breast Neoplasms
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gierisch, J. M., Coeytaux, R. R., Urrutia, R. P., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., … Myers, E. R. (2013). Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev, 22(11), 1931–1943. https://doi.org/10.1158/1055-9965.EPI-13-0298
Gierisch, Jennifer M., Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.Cancer Epidemiol Biomarkers Prev 22, no. 11 (November 2013): 1931–43. https://doi.org/10.1158/1055-9965.EPI-13-0298.
Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1931–43.
Gierisch, Jennifer M., et al. “Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.Cancer Epidemiol Biomarkers Prev, vol. 22, no. 11, Nov. 2013, pp. 1931–43. Pubmed, doi:10.1158/1055-9965.EPI-13-0298.
Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1931–1943.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

November 2013

Volume

22

Issue

11

Start / End Page

1931 / 1943

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • Ovarian Neoplasms
  • Humans
  • Female
  • Epidemiology
  • Endometrial Neoplasms
  • Contraceptives, Oral
  • Breast Neoplasms
  • 42 Health sciences
  • 32 Biomedical and clinical sciences